HK1252848A1 - 製備取代的3-(2-苯胺基-1-環己基-1h-苯並咪唑-5-基)丙酸衍生物的方法 - Google Patents
製備取代的3-(2-苯胺基-1-環己基-1h-苯並咪唑-5-基)丙酸衍生物的方法Info
- Publication number
- HK1252848A1 HK1252848A1 HK18112179.8A HK18112179A HK1252848A1 HK 1252848 A1 HK1252848 A1 HK 1252848A1 HK 18112179 A HK18112179 A HK 18112179A HK 1252848 A1 HK1252848 A1 HK 1252848A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- benzimidazol
- anilino
- cyclohexyl
- acid derivatives
- propanoic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15178413 | 2015-07-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1252848A1 true HK1252848A1 (zh) | 2019-06-06 |
Family
ID=53758091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18112179.8A HK1252848A1 (zh) | 2015-07-27 | 2018-09-21 | 製備取代的3-(2-苯胺基-1-環己基-1h-苯並咪唑-5-基)丙酸衍生物的方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10703727B2 (zh) |
| EP (1) | EP3328838A1 (zh) |
| JP (1) | JP6787998B2 (zh) |
| KR (1) | KR20180030906A (zh) |
| CN (1) | CN107848985B (zh) |
| AR (1) | AR105494A1 (zh) |
| AU (1) | AU2016299329B2 (zh) |
| BR (1) | BR112018001535A2 (zh) |
| CA (1) | CA2993480A1 (zh) |
| CL (1) | CL2018000241A1 (zh) |
| CO (1) | CO2018000795A2 (zh) |
| HK (1) | HK1252848A1 (zh) |
| IL (1) | IL256926A (zh) |
| MX (1) | MX2018001204A (zh) |
| PE (1) | PE20181039A1 (zh) |
| RU (1) | RU2018106948A (zh) |
| TW (1) | TW201718513A (zh) |
| WO (1) | WO2017017046A1 (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU24410B1 (es) | 2014-02-11 | 2019-05-03 | Bayer Pharma AG | Benzimidazol-2-aminas como inhibidores de midh1 |
| CN105980365B (zh) | 2014-02-11 | 2019-06-21 | 拜耳医药股份公司 | 作为mIDH1抑制剂的苯并咪唑-2-胺 |
| CN107108554B (zh) | 2014-10-23 | 2020-11-06 | 德国癌症研究中心 | 作为midh1抑制剂用于治疗肿瘤的1-环己基-2-苯基氨基苯并咪唑 |
| CA2988356A1 (en) | 2015-06-08 | 2016-12-15 | Bayer Pharma Aktiengesellschaft | N-menthylbenzimidazoles as midh1 inhibitors |
| JP6824952B2 (ja) | 2015-07-07 | 2021-02-03 | ドイチェス クレープスフォルシュングスツェントルム シュティフトゥング デス エッフェントリッヒェン レヒツ | ｍＩＤＨ１阻害剤としての２−アリール−および２−アリールアルキル−ベンズイミダゾール |
| WO2017009325A1 (en) | 2015-07-16 | 2017-01-19 | Bayer Pharma Aktiengesellschaft | 5-hydroxyalkylbenzimidazoles as midh1 inhibitors |
| EP3121166A1 (en) | 2015-07-21 | 2017-01-25 | Bayer Pharma Aktiengesellschaft | Fused imidazoles as midh1 inhibitors |
| TW201708193A (zh) * | 2015-07-27 | 2017-03-01 | 拜耳製藥公司 | 突變之異檸檬酸脫氫酶ｉｄｈ１ ｒ１３２ｈ之抑制劑 |
| EP3661559A1 (en) | 2017-08-01 | 2020-06-10 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Combination of midh1 inhibitors and dna hypomethylating agents (hma) |
| EA202190009A1 (ru) * | 2018-06-26 | 2021-03-25 | Кпс Фармасьютикалз, Инк. | Производные бензимидазола и их применение в качестве ингибиторов idh1 |
| TWI760017B (zh) * | 2019-12-23 | 2022-04-01 | 大陸商昆藥集團股份有限公司 | 一種ｉｄｈ１突變體抑制劑的鹽型、晶型及其製備方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2766550C (en) | 2009-06-23 | 2017-04-11 | The Translational Genomics Research Intstitute | Benzamide derivatives |
| CU24410B1 (es) * | 2014-02-11 | 2019-05-03 | Bayer Pharma AG | Benzimidazol-2-aminas como inhibidores de midh1 |
| CN105980365B (zh) | 2014-02-11 | 2019-06-21 | 拜耳医药股份公司 | 作为mIDH1抑制剂的苯并咪唑-2-胺 |
| CN107108554B (zh) | 2014-10-23 | 2020-11-06 | 德国癌症研究中心 | 作为midh1抑制剂用于治疗肿瘤的1-环己基-2-苯基氨基苯并咪唑 |
| WO2016062677A1 (en) | 2014-10-23 | 2016-04-28 | Bayer Pharma Aktiengesellschaft | Benzimidazol-2-amines as midh1 inhibitors |
| CA2988356A1 (en) | 2015-06-08 | 2016-12-15 | Bayer Pharma Aktiengesellschaft | N-menthylbenzimidazoles as midh1 inhibitors |
| JP6824952B2 (ja) | 2015-07-07 | 2021-02-03 | ドイチェス クレープスフォルシュングスツェントルム シュティフトゥング デス エッフェントリッヒェン レヒツ | ｍＩＤＨ１阻害剤としての２−アリール−および２−アリールアルキル−ベンズイミダゾール |
| WO2017009325A1 (en) | 2015-07-16 | 2017-01-19 | Bayer Pharma Aktiengesellschaft | 5-hydroxyalkylbenzimidazoles as midh1 inhibitors |
| EP3121166A1 (en) | 2015-07-21 | 2017-01-25 | Bayer Pharma Aktiengesellschaft | Fused imidazoles as midh1 inhibitors |
| TW201708193A (zh) | 2015-07-27 | 2017-03-01 | 拜耳製藥公司 | 突變之異檸檬酸脫氫酶ｉｄｈ１ ｒ１３２ｈ之抑制劑 |
-
2016
- 2016-07-14 TW TW105122263A patent/TW201718513A/zh unknown
- 2016-07-25 WO PCT/EP2016/067614 patent/WO2017017046A1/en active Application Filing
- 2016-07-25 PE PE2018000132A patent/PE20181039A1/es unknown
- 2016-07-25 RU RU2018106948A patent/RU2018106948A/ru not_active Application Discontinuation
- 2016-07-25 US US15/748,027 patent/US10703727B2/en active Active
- 2016-07-25 AU AU2016299329A patent/AU2016299329B2/en not_active Ceased
- 2016-07-25 KR KR1020187005191A patent/KR20180030906A/ko unknown
- 2016-07-25 CN CN201680043928.5A patent/CN107848985B/zh active Active
- 2016-07-25 MX MX2018001204A patent/MX2018001204A/es unknown
- 2016-07-25 EP EP16741641.1A patent/EP3328838A1/en not_active Withdrawn
- 2016-07-25 BR BR112018001535A patent/BR112018001535A2/pt not_active Application Discontinuation
- 2016-07-25 JP JP2018504195A patent/JP6787998B2/ja active Active
- 2016-07-25 CA CA2993480A patent/CA2993480A1/en not_active Abandoned
- 2016-07-27 AR ARP160102275A patent/AR105494A1/es unknown
-
2018
- 2018-01-15 IL IL256926A patent/IL256926A/en unknown
- 2018-01-26 CO CONC2018/0000795A patent/CO2018000795A2/es unknown
- 2018-01-26 CL CL2018000241A patent/CL2018000241A1/es unknown
- 2018-09-21 HK HK18112179.8A patent/HK1252848A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN107848985B (zh) | 2021-09-03 |
| CO2018000795A2 (es) | 2018-05-10 |
| US10703727B2 (en) | 2020-07-07 |
| CA2993480A1 (en) | 2017-02-02 |
| TW201718513A (zh) | 2017-06-01 |
| CL2018000241A1 (es) | 2018-07-13 |
| CN107848985A (zh) | 2018-03-27 |
| RU2018106948A (ru) | 2019-08-27 |
| KR20180030906A (ko) | 2018-03-26 |
| MX2018001204A (es) | 2018-04-24 |
| AU2016299329A1 (en) | 2018-02-01 |
| JP6787998B2 (ja) | 2020-11-18 |
| US20180222871A1 (en) | 2018-08-09 |
| JP2018527328A (ja) | 2018-09-20 |
| WO2017017046A1 (en) | 2017-02-02 |
| AU2016299329B2 (en) | 2020-08-13 |
| AR105494A1 (es) | 2017-10-11 |
| BR112018001535A2 (pt) | 2018-09-18 |
| EP3328838A1 (en) | 2018-06-06 |
| IL256926A (en) | 2018-03-29 |
| PE20181039A1 (es) | 2018-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1252848A1 (zh) | 製備取代的3-(2-苯胺基-1-環己基-1h-苯並咪唑-5-基)丙酸衍生物的方法 | |
| SG11201707009TA (en) | Process for producing acetic acid | |
| SG11201609591PA (en) | Process for preparing an unsaturated carboxylic acid salt | |
| IL262149A (en) | A method of producing lactic acid | |
| EP3309258A4 (en) | PROCESS FOR PREPARING 3-HYDROXYADIPIC ACID | |
| SG11201802571YA (en) | Method for producing acetic acid | |
| EP3309259A4 (en) | Method for producing -hydromuconic acid | |
| EP3358016A4 (en) | Method for producing hydroxy-l-pipecolic acid | |
| SG11201706506YA (en) | Acetic acid process | |
| SG11201706008YA (en) | Processes for producing acetic acid | |
| HUE061332T2 (hu) | Eljárás aminobenzoesav vagy aminobenzoesav-származék elõállítására | |
| EP3388525A4 (en) | PROCESS FOR PRODUCING 3-OXOADIPIC ACID | |
| EP3284748A4 (en) | Method for preparing deoxycholic acid | |
| HK1243708A1 (zh) | 用於製備2-糠酸衍生物的合成方法 | |
| SI3386947T1 (sl) | Postopek za pripravo N-retinoilaminoalkansulfonske kisline | |
| HK1256031A1 (zh) | 新的4-苯並偶氮寧衍生物的製造方法 | |
| RS62896B1 (sr) | Proces za proizvodnju sirćetne kiseline | |
| SG11201707217TA (en) | Processes for producing acetic acid | |
| SG11201702408UA (en) | Process for producing acetic acid | |
| PL3322688T3 (pl) | Sposób wytwarzania kwasu bursztynowego | |
| EP3281938A4 (en) | Method for producing bisimidodicarboxylic acid | |
| SG11201802063XA (en) | Processes for producing acetic acid | |
| EP3318550A4 (en) | Method for preparing benzoic acid amide compound | |
| SG11201706006VA (en) | Processes for producing acetic acid | |
| HK1251233A1 (zh) | 製備二羧酸化合物的方法 |